SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

NGL Fine-Chem informs about credit rating

13 Mar 2026 Evaluate

Pursuant to Regulation 30 read with Schedule III of the SEBI Listing Obligations and Disclosure Requirements), Regulations, 2015, NGL Fine-Chem has informed that, Crisil Ratings vide their letter dated March 12, 2026 has revised its outlook on the long-term bank loan facilities of the Company to ‘Stable’ from ‘Negative’ while reaffirming the rating at ‘Crisil BBB+’. The Short term rating has been reaffirmed at 'Crisil A2'.

The above information is a part of company’s filings submitted to BSE.

NGL Fine-Chem Share Price

3180.60 243.15 (8.28%)
03-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1904.65
Dr. Reddys Labs. 1374.55
Cipla 1458.45
Zydus Lifesciences 1141.00
Lupin 2476.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: